Breast cancerPancreatic cancerColorectal cancerThyroid cancerOvarian cancer
Established
1931
Beds
2,100+
Annual Volume
2,000,000+
Shanghai
One of China’s oldest cancer hospitals (est. 1931), nationally leading in breast and pancreatic cancer outcomes.
About the Hospital
Fudan University Shanghai Cancer Center is one of China’s oldest cancer specialty hospitals (founded in 1931 as the Sino-Belgian Radium Institute), internationally renowned for breast cancer, head-and-neck tumors, soft-tissue tumors and pathology — its pathology department is the national consultation center for difficult cases.
The hospital runs integrated outpatient–inpatient–follow-up continuum management, and its multidisciplinary breast-cancer model has become a national paradigm; the Pudong campus further expands radiotherapy and international-care capacity.
Hospital Strengths
01Top-tier breast cancer program
Its breast MDT handles among the largest annual volumes in China, with leading breast-conservation and reconstruction rates; the “Fudan classification” for triple-negative breast cancer entered international guideline discussions.
02National pathology consultation center
The pathology department completes tens of thousands of outside difficult-case reviews annually and is nationally authoritative for soft-tissue tumor and lymphoma diagnostics.
03Function-preserving head-and-neck surgery
The head-and-neck team is highly experienced in function-preserving surgery and immediate reconstruction for thyroid, oral and laryngeal cancers, markedly improving postoperative quality of life.
01Breast-cancer multimodality care with conservation/reconstruction
02Radical and reconstructive head-and-neck surgery
03Comprehensive care for soft-tissue sarcoma and melanoma
04Minimally invasive GI cancer surgery and comprehensive care
05Difficult-case pathology review and molecular diagnostics
06Precision prostate-cancer care (PSMA PET / robotic surgery)
Officially Reported Treatment Milestones
Fudan classification precision treatment system for triple-negative breast cancer
2019
Prof. Shao Zhimin’s team proposed the molecular subtyping of triple-negative breast cancer (Fudan classification), enabling subtype-guided precision treatment; results were published in Cancer Cell and translated into clinical trial series.
Multidisciplinary team (MDT) clinic model for breast cancer
2010–
One of the first centers in China to establish a breast cancer MDT clinic; annual breast surgery volume ranks among the nation’s highest, with 5-year survival at an internationally advanced level.